LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways

Seung Woo Chung, Sang Mun Bae, Myungjin Lee, Taslim A. Al-Hilal, Chang Kyung Lee, Jeong Kon Kim, In-San Kim, Sang Yoon Kim, Youngro Byun

Research output: Contribution to journalArticle

21 Citations (Scopus)

Fingerprint Dive into the research topics of 'LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways'. Together they form a unique fingerprint.

Engineering & Materials Science

Chemical Compounds

Medicine & Life Sciences